July 12, 2017 |SOURCE: PR NEWSWIRE

Regen BioPharma, Inc. Researchers Discover New Dynamic Compound Which Modulates the NR2F6 Checkpoint
New compound appears to be 10-fold more effective than previous compounds tested while showing no toxicity